Wall Street Zen Downgrades Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) to Buy

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) was downgraded by equities research analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Saturday.

Other equities research analysts also recently issued reports about the company. Erste Group Bank downgraded Fresenius Medical Care AG & Co. KGaA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, February 5th. The Goldman Sachs Group cut Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “neutral” rating in a research note on Tuesday, January 20th. Morgan Stanley reiterated an “underweight” rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Tuesday, January 27th. Truist Financial set a $28.00 price target on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Monday, January 5th. Finally, Weiss Ratings cut shares of Fresenius Medical Care AG & Co. KGaA from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, March 13th. Five investment analysts have rated the stock with a Hold rating and four have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Reduce” and a consensus price target of $28.00.

Fresenius Medical Care AG & Co. KGaA Trading Up 0.2%

NYSE FMS opened at $22.45 on Friday. The firm’s 50 day moving average price is $23.09 and its two-hundred day moving average price is $24.01. The company has a debt-to-equity ratio of 0.40, a quick ratio of 0.92 and a current ratio of 1.26. Fresenius Medical Care AG & Co. KGaA has a twelve month low of $20.94 and a twelve month high of $30.46. The stock has a market cap of $12.54 billion, a price-to-earnings ratio of 11.75, a PEG ratio of 2.12 and a beta of 0.89.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last released its earnings results on Saturday, February 14th. The company reported $1.69 earnings per share (EPS) for the quarter. The company had revenue of $5.95 billion during the quarter. Fresenius Medical Care AG & Co. KGaA had a return on equity of 8.73% and a net margin of 5.03%. Equities analysts anticipate that Fresenius Medical Care AG & Co. KGaA will post 1.51 EPS for the current year.

Institutional Investors Weigh In On Fresenius Medical Care AG & Co. KGaA

Several institutional investors and hedge funds have recently modified their holdings of the business. Pzena Investment Management LLC increased its position in Fresenius Medical Care AG & Co. KGaA by 1.0% during the third quarter. Pzena Investment Management LLC now owns 14,816,852 shares of the company’s stock worth $390,128,000 after buying an additional 153,870 shares during the last quarter. Morgan Stanley lifted its position in shares of Fresenius Medical Care AG & Co. KGaA by 47.2% in the fourth quarter. Morgan Stanley now owns 2,939,839 shares of the company’s stock worth $70,027,000 after buying an additional 942,497 shares during the last quarter. Todd Asset Management LLC lifted its position in shares of Fresenius Medical Care AG & Co. KGaA by 5.2% in the third quarter. Todd Asset Management LLC now owns 1,303,424 shares of the company’s stock worth $34,319,000 after buying an additional 64,311 shares during the last quarter. Teachers Retirement System of The State of Kentucky boosted its stake in shares of Fresenius Medical Care AG & Co. KGaA by 8.3% during the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 816,200 shares of the company’s stock worth $21,491,000 after acquiring an additional 62,700 shares in the last quarter. Finally, Integral Health Asset Management LLC boosted its stake in shares of Fresenius Medical Care AG & Co. KGaA by 44.4% during the 4th quarter. Integral Health Asset Management LLC now owns 650,000 shares of the company’s stock worth $15,483,000 after acquiring an additional 200,000 shares in the last quarter. Institutional investors and hedge funds own 8.37% of the company’s stock.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.